Cowen Downgrades PTC Therapeutics (PTCT) to Market Perform
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $68.01 -9.94%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
Cowen downgraded PTC Therapeutics (NASDAQ: PTCT) from Outperform to Market Perform with a price target of $45.00.
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $45.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PTC Therapeutics (PTCT) PT Raised to $106 at Wells Fargo
- Kotak Downgrades Dixon Technologies India Ltd (DIXON:IN) to Add (2)
- JPMorgan Downgrades Mankind Pharma Ltd (MANKIND:IN) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
